Rehab that follows you home the HEAD pilot.

What did the HEAD study actually do?

The HEAD program (Human Empowerment Aging and Disability) built a VR system for combined motor and cognitive rehabilitation, and tested it in two stages. First, all 34 participants, chronic stroke survivors at least six months out, past the window of spontaneous recovery, completed a supervised VR program in the clinic. Then eleven took the system home for three months of tele-monitored use, while twenty-three continued with usual care, and everyone was assessed out to six months by blinded raters.

The uneven 1:2 split was pragmatic, allocation was limited by available equipment, and it is one of the study's acknowledged weaknesses. The daily home practice mixed exercise types: on average 35.3 minutes of VR per day, split across motor (18.6 minutes), cognitive (10.7), and occupational (6.3) tasks.

Assessment covered walking capacity and speed (2-minute and 10-meter walk tests), balance (Berg Balance Scale), cognition (Montreal Cognitive Assessment), and memory (Rivermead Behavioural Memory Test), a broader net than most motor-rehab trials cast.

What did the results show, phase by phase?

Clinic phase: broad gains, no control

After the supervised clinic program, the 34 participants improved significantly on nearly everything measured: 2-minute walk distance (p = 0.011, effect size d = 0.894), 10-meter walk speed (p = 0.006, d = 1.071), Berg balance (p = 0.010, d = 1.067), MoCA cognition (p = 0.001, d = 1.253), and memory (p = 0.031, d = 0.817). In chronic stroke, where the natural trajectory is flat or declining, gains of this breadth are notable, but with no control group, expectation, attention, and extra activity of any kind remain unruled-out explanations.

Home phase: no separation at three months, then the follow-up story

During the three-month home intervention itself, change scores did not differ significantly between the home-VR and usual-care groups. The interesting divergence appeared at six months: the home group maintained its functional mobility (2-minute walk, p = 0.032 versus usual care), while the usual-care group's walking distance declined significantly (p = 0.02). The home group also improved on memory (p = 0.001).

Why is the adherence finding the important one?

Because adherence is where home rehabilitation dies. The standard of care after discharge is a home exercise sheet, and the quiet consensus in rehabilitation is that most of those sheets go un-exercised. Against that baseline, 89% completion of sixty prescribed home sessions, roughly 55 sessions actually done, with 35 minutes of daily practice, is a striking behavioral result in its own right.

The supporting numbers cohere: 92% adherence in the clinic phase, a median System Usability Scale score of 77.5 out of 100 from a cohort with a mean age of 59 using a technology stereotyped as belonging to their grandchildren, and zero study-related adverse events across both phases.

This matters beyond stroke because dose and consistency are the currency of every retraining-based therapy. Whatever the eventual verdict on VR's specific efficacy, a delivery channel that multiplies completed practice is valuable, the same argument that surfaced in the engagement data of the subacute stroke meta-analysis.

What does this mean for remote rehabilitation and chronic pain care?

The study's limitations should be listed without flinching: a small, equipment-constrained allocation; a passive control that received no comparable attention; eligibility that excluded significant cognitive impairment and required standing tolerance; and follow-up capped at six months. Every efficacy signal here is a hypothesis for the larger trial the authors themselves call for.

What the pilot establishes more firmly is the model: clinic onboarding, then supervised technology at home, with remote monitoring keeping clinicians in the loop. That architecture is spreading across neurorehabilitation and is the backbone of virtual-first chronic pain treatment, including Karuna's program, where a headset ships to the patient and coaching happens remotely across twelve weeks.

For chronic pain specifically, the maintenance framing translates naturally. Retraining a sensitized pain system, like retraining a hemiparetic gait, is not an event but a practice, and practices survive on convenience. Care that lives where the patient lives, the theme running from bedside MRI to this study, is how practices survive. Our guide to VR pain management covers what the practice consists of.